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Objective The coronavirus disease 2019 (COVID-19) is a pandemic viral disease,
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact
of the disease among the obstetric population remains unclear, and the study of the
placenta can provide valuable information. Adequate sampling of the placental tissue
can help characterize the pathways of viral infections.
Methods A protocol of placental sampling is proposed, aiming at guaranteeing
representativity of the placenta and describing the adequate conservation of samples
and their integrity for future analysis. The protocol is presented in its complete and
simpliﬁed versions, allowing its implementation in different complexity settings.
Results Sampling with the minimum possible interval from childbirth is the key for
adequate sampling and storage. This protocol has already been implemented during
the Zika virus outbreak.
Conclusion A protocol for adequate sampling and storage of placental tissue is
fundamental for adequate evaluation of viral infections on the placenta. During the
COVID-19 pandemic, implementation of this protocol may help to elucidate critical
aspects of the SARS-CoV-2 infection.
Objetivo A doença do novo coronavírus (COVID-19) é uma doença viral pandêmica
causada pelo coronavírus da síndrome respiratória aguda 2 (SARS-CoV-2). O impacto da
doença entre a população obstétrica ainda é incerto, e o estudo da placenta pode
fornecer informações valiosas. Assim, a coleta adequada do tecido placentário pode
ajudar a caracterizar algumas propriedades das infecções virais.
Métodos Um protocolo de coleta placentária é proposto, objetivando a garantia de
representatividade da placenta, descrevendo a maneira de conservação adequada das
amostras, e visando garantir sua integridade para análises futuras. O protocolo é
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apresentado em suas versões completa e simpliﬁcada, permitindo sua implementação
em diferentes conﬁgurações de infraestrutura.
Resultados A amostragem com o intervalo mínimo possível do parto é essencial para
coleta e armazenamento adequados. Esse protocolo já foi implementado durante a
epidemia de vírus Zika.
Conclusão Um protocolo para coleta e armazenamento adequados de tecido placentário é fundamental para a avaliação adequada de infecções virais na placenta.
Durante a pandemia de COVID-19, a implementação deste protocolo pode ajudar a
elucidar aspectos críticos da infecção por SARS-CoV-2.

Introduction
Coronavirus disease 2019 (COVID-19) is a severe and highly
relevant viral disease in the global scenario. Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) (family
Coronaviridae, genus Betacoronavirus), the etiological agent
of the disease, causes asymptomatic or a mild respiratory
infection in the majority of cases.1–4 However, people with
underlying risk factors, such as increased age, cardiovascular
disease, and diabetes, present higher rates of clinical complications and severe acute respiratory syndrome (SARS).4
In viruses of the same genus, such as SARS-CoV (subgenus
Sarbecovirus) and Middle East respiratory syndrome coronavirus (MERS-CoV) (subgenus Merbecovirus), as well as in other
respiratory disease viruses, there is an increased risk of
morbidity and mortality during pregnancy.3,5–8 The impact
of COVID-19 on the obstetric population and the gestational
consequences of SARS-CoV-2 are a great concern for investigation.9–11 Data from the United Kingdom show that most
women admitted with SARS-CoV-2 infection during pregnancy were in the late second or third trimester, which replicates
the pattern seen for other respiratory viruses, with women in
later pregnancy being more severely affected, a third of whom
had preexisting comorbidities.12 In United States, reports
show higher rates of hospitalization (31.5%), intensive care
unit (ICU) admission (1.5%), and mechanical ventilation
(0.5%) in pregnant women, when compared with nonpregnant
women (5.8%, 0.9%, 0.3%, respectively).13 Thus, recent data
from Brazil have demonstrated an increased risk of severity
among pregnant women, with high numbers of maternal
death, and signiﬁcant cases without adequate respiratory
support and with no intensive care admissions.14
To understand the different facets of COVID-19 during
pregnancy, the placenta can serve as a valuable source of
information about maternal and fetal conditions. The placenta
is a complex and unique interface between maternal and fetal
vascular beds, mediating the exchange of nutrients and others
residues, allowing the fetal uterine existence and maintaining a
highly reliable homeostasis.15,16 The broad spectrum of placental functions depends on its tissues and cellular stratiﬁcation,
which form a selective biological barrier, called the
blood-placental barrier.17 Those tissues may be affected by viral
infections, such as parvovirus B19, rubella virus, cytomegalovirus, herpes simplex viruses, and Zika virus (ZIKV), and the
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consequences of the placental tissues’ immune response and
destruction during different periods of pregnancy can lead to
severe consequences on gestational and neonatal outcomes.18
The current evidences about vertical transmission are
uncertain and the preponderance of evidence so far does
not indicate a signiﬁcant role for vertical transmission.5,10,19
However, to understand the impact of COVID-19 on maternal
morbidity and mortality is crucial, and the evaluation of the
placental tissue may provide data about pathways related to
the viral infection within the placenta.20 Recent placental
histopathology results from SARS-CoV-2-positive women
did not demonstrate a speciﬁc pathology or pathological
pattern; however, nonspeciﬁc histomorphologic changes
suggestive of maternal/fetal vascular malperfusion have
been reported.21 Viral particles in the organ has been
detected, although aspects of the effects and pathways of
infection by SARS-CoV-2 and how it occurs on placental
tissues remain largely unknown up to this date.21–24
Our group has previously shown, during the ZIKV
outbreak in Brazil, that the placenta is a possible site for
viral persistence and that viral detection relies on adequate
and appropriate sampling and storage.25 Thus, here we detail
sampling procedures and also propose a simple protocol that
can be performed in the delivery room, to guarantee representative tissues of placenta, allowing further investigation
consequences of viral infection in pregnancy, including
SARS-CoV-2 infection.

Methods
Placental Sampling Protocol
The placental sampling protocol aims to represent the various
tissues that constitute the placenta, and also the umbilical
cord, at the time of childbirth. The sampling includes 4 regions
of the placenta: the basal plate, the chorionic villus, the
chorionic plate, and the amniotic membrane (►Fig. 1). To
preserve the best sampling quality, collection should be
performed in the shortest possible interval from childbirth.
Due to different conditions for sampling in different facilities,
two versions of the protocol are proposed, the complete
(►Fig. 1A) and the simpliﬁed (►Fig. 1B). All procedures
must be performed following the local biosafety rules. The
current manuscript is a protocol description. Each study that
implements it must necessarily undergo appropriate ethical
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Fig. 1 Cross section of the placenta showing its components in
different versions of the protocol—complete (A) and simpliﬁed (B)
placental protocol version.

Fig. 2 Placental sampling based on umbilical cord insertion
site — central (A) and peripheral (B) insertion.

approval. The protocol was approved by the ethics committee
of the coordinating center (#4.047.168) and of each participating center, with implementation in 5 obstetric reference
centers of the Brazilian Network of COVID-19 during Pregnancy
(REBRACO, in the Portuguese acronym) up to now.26 The latest
World Health Organization (WHO) recommendations for
sampling COVID-19 patients include a biosafety level 2
(BSL2) facility with all adequate caution.27 Speciﬁc procedures
with high viral load, like viral isolation, must be conducted in
biosafety level 3 (BSL3) facilities.28

Complete Placental Sampling
After childbirth, the placenta should be immediately prepared for sampling or preserved in a cool refrigerator (4°C) in
a sterile container for a maximum of 2 hours after childbirth
until sampling is possible. The processing of the placenta
must be done in an adequate sterile hood; the materials and
equipment necessary for adequate placental sampling are
described in Supplementary Data S1 (online only). Placental
samples will be stored in cryotubes and histology cassettes.
All storage materials must be properly identiﬁed before the
procedure, with patient identiﬁcation and corresponding
placental region.
The ﬁrst step is to have the placenta washed, with sterile
saline or sterile phosphate buffer saline, inside a tray, and any
solid residues or visible blood clots must be removed. After
cleaning, the placenta is placed on a surface with sterile
absorbent paper with the basal plate facing up. The choice of
the sampling locals to ensure representativeness is based on
the insertion of the umbilical cord (►Fig. 2). In placentas with
umbilical cord centrally inserted, three imaginary concentric
circles (one coincident with the placental disc borders, one
marginal to the umbilical cord, and a third placed between
those two previously described) should be projected, and the
sampling places are positioned in the intermediate circle. Four
points are chosen in the intermediate circle for sampling,
equidistant from each other (►Fig. 2A). In placentas with
Rev Bras Ginecol Obstet
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peripheral cord insertion, three concentric semi-circles
starting from the cord insertion site should be considered,
and sampling will be performed in the intermediate circle
(►Fig. 2B). The areas where the sampling take place must not
contain macroscopic anomalies, such as areas of detachment
or extensive calciﬁcation.
After the sampling areas are deﬁned, tissues are sampled in
the following order: basal plate, chorionic villus, amniotic
membrane, chorionic plate, and umbilical cord (►Fig. 1A).
The basal plate corresponds to the maternal face of the
placenta; at the sampling places, an incision should be made
with the scalpel 5 mm deep, seeking to avoid contamination
with villi. Chorionic villus corresponds to the tissue underlying
the basal plate; superﬁcial tissue must be despised because it
may contain traces of the basal plate. The amniotic membrane
corresponds to the thin and transparent membrane that lines
the chorionic plate; to acquire it, this layer must be detached
from the chorionic plate. The chorionic plate corresponds to
the fetal face of the placenta; it is necessary to dissect the
amniotic membrane previously and collect the tissue below, 
2 mm thick, and visible calibrated blood vessels should be
avoided. Finally, for the umbilical cord, samples are obtained
sectioning it transversely, to obtain two samples.
Samples of 15  15  15 mm (except for the amniotic
membrane, where the sample is 10  5  2 mm) are initially obtained, from each placental region, and, further, each
of these pieces are divided in 3 equal parts (technical
triplicate). Umbilical cord samples 10 mm thick and divided in 3 equal parts are also obtained.
Each tissue sampling has two storage destinations: histology
cassettes for formalin ﬁxation and cryotubes for cryopreservation. One of three parts of each sample replica will be stored in a
cassette, that will in the end contain four samples, one from
each previously selected region — again focusing on representativeness (►Fig. 3A). Two of three parts of each replica will be
placed in two cryotubes, each containing 4 samples, one from
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Fig. 3 Tissue sample storage process for each sampling site. (A). Histology cassettes storage. (B). Cryotube storage.

each previously selected local, guaranteeing the representativeness of the placenta (►Fig. 3B). The umbilical cord samples
follow the same storage method: the histology cassette and
each cryotube present two fragments of total section of the
tissue.

Simpliﬁed Placental Sampling
After childbirth, the placenta can be immediately sampled in
the operating room, by the responsible delivery team, after
adequate training. This can mitigate any concerns regarding
biosafety standards, materials usage, and adequate use of
appropriate personal protective equipment (PPE) (Supplementary Data 1). All storage material must be properly identiﬁed
with the patient coding, as previously proposed for the complete
placental sampling.
The selection of sampling areas to ensure representativeness is the same as that applied for the complete placental
sampling, and it is based on the insertion of the umbilical
cord, deﬁning four places (►Fig. 2). When obtaining such
samples, there is no detail on the different regions, and
the samples must contain almost the full thickness of the
placenta, removing the more superﬁcial maternal tissue and
focusing on collecting the villous tissue in deeper regions
(►Fig. 1B). Samples of 15  15  15 mm are obtained from
each local.
The samples collected are stored in cryotubes, each containing a sample from a previously selected area, and properly
preserved after childbirth. To guarantee representativeness of
the placenta, analysis with samples obtained with simpliﬁed
placental sampling must use material from the four sampling
areas for each assay (►Fig. 4). After sampling in the operating
room, the placenta should be sent for routine pathological
analysis.

Storage and Cautions
Placenta samples in histology cassettes must be placed in a
ﬁxative solution, such as 10% buffered formalin, and then be
Rev Bras Ginecol Obstet
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processed for embedding, which can be made in parafﬁn or
other material (►Fig. 3A). Cryotubes containing samples
must be preserved immediately at very low temperatures
to maintain sample integrity. Cryotubes must be stored in a
liquid nitrogen (N2) container or directly in -80°C freezer.
Low temperatures must be maintained in the ﬁnal accommodation (►Fig. 3B). Biosafety guidelines must be followed
during all manipulation of samples: sampling, freezing,
storing, and processing.27,28 All disposable materials used
during the sampling process must be considered as infectious waste. Other materials must be cleaned and sterilized,
preferably in an initial 10% sodium hypochlorite solution.27

Histopathological Analysis
The placenta should be further considered for histopathological examination. After the sampling protocol process is
ﬁnished, the placenta should be placed in a container with
an adequate volume of buffered formalin and sent for
histopathological analysis. The sampling and analysis of
normal and abnormal ﬁndings should follow the
Amsterdam Placental Workshop Group Consensus
Statements, to enable comparison and international standardization of report results.29 A consistent understanding,
with basic gross examination and histologic patterns of
injury is important to maximize the diagnostic, prognostic,
and therapeutic beneﬁt of placental examination.30

Results and Discussion
Adequate placental sampling is key to the evaluation of different insults that may affect the placenta, the woman, and the
fetus. We described a placental sampling protocol, which has
already been implemented in our setting and allowed us to
provide some evidence regarding ZIKV infection during
pregnancy.25 Conserving the integrity of placental samples
enables future analysis, using molecular biology and biochemistry techniques.

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. All rights reserved.
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Fig. 4 Placenta sample storage process for simpliﬁed protocol version.

Immunohistochemistry, immunoﬂuorescence, and a series
of different stains, such as the commonly used hematoxylin and
eosin stain, can be performed in the histological samples
obtained from parafﬁn-embedded tissue cassettes. Using
samples preserved in cryotubes, after speciﬁc treatments and
extractions, experiments and assays based on proteins (such as
Western-blot and proteomic analyzes) or nucleic acids (such as
qPCR and next-generation sequencing), or even lipids and other
biomolecules, can be implemented. We highlight that some
samples are more appropriate than others for speciﬁc assays. As
a relevant example, formalin-ﬁxated and parafﬁn-embedded
samples could lead to some methodological difﬁculties for the
detection and testing of ribonucleic acid (RNA) viruses, while
cryogenic stored samples are more adequate for such
experiments.
In addition to maintaining the placental characteristics
most similar to those at the moment of childbirth, the
sampling is also representative of the placenta as an organ.
The samples are collected from areas where the thickness of
the placenta is regular, according to its distance from the
umbilical cord’s spot of insertion. By sampling in random
equidistant regions, representativeness of the entire placenta is obtained, thus reducing the interference of speciﬁc site
features (outliers) and bias in future analyses.
Due to the recommended sampling and subsequent
adequate storage, the samples maintain the integrity of the
biomolecules. In a previous study from our research group, in
which the detailed placental protocol sampling was applied,
it was possible to extract whole RNA molecules from samples
preserved in -80°C freezers for periods of up to 2 years. This
research made it possible to identify the ZIKV genome in
placenta samples. This study suggested that, a simpliﬁed
protocol, mainly with villous tissue samples, if respecting
representativeness and adequate storage of the material,
could be effective for viral detection.25 However, inadequate
placental sampling can be distracting and generate misleadRev Bras Ginecol Obstet

Vol. 43

ing results; for that reason, all studies involving placental
samples should detail the procedure.31
The infection routes of SARS-CoV-2 regarding vertical transmission remain unclear, and there is limited information about
COVID-19 during pregnancy and its consequences.10,11,32–34
Some cellular components have been considered as putative
binding receptors for viral entry, such as the membrane protein
angiotensin-converting enzyme 2 (ACE2), which is widely
expressed in the surface of trophoblasts and endothelial
cells.35–37 Recent studies suggest the ACE2 as part of the viral
adsorption, and due to its expression in placental cells, it could
possibly lead to a placental infection.38,39 Early studies published had not reported detection of the SARS-CoV-2 genome
by reverse transcription-polymerase chain reaction (RT-PCR)
assays in placental samples; however, details regarding the
methodological process (sampling method, processing
time, sample storage) are not clear and, therefore, did not
rule out the possibility of viral presence at the maternal-fetal
interface, which has now been shown.40,41 Recent results
demonstrated the presence and infection of the virus in the
placental tissue, mainly in the chorionic villi, an area emphasized in the current protocol.22–24 A study involving 19
pregnant women infected with SARS-CoV-2 indicated the viral
infection in villi syncytiotrophoblast and cytotrophoblasts by
in-situ hybridization technique (nucleic-acid based technique),
with a speciﬁc target for the SARS-CoV-2 RNA.23
As well as the ZIKV, SARS-CoV-2 contains a positive-sense
single-stranded RNA genome.1,3,42 Given the previous experience to detect the ZIKV genome in placentas sampled by
this protocol,25 investigation of the COVID-19 virus could
beneﬁt from this protocol. Therefore, the implementation of
the simpliﬁed protocol focusing on the chorionic villi can
enable a greater scope of biological material sampling in
different reference centers, mainly in countries with a severe
pandemic scenario in the obstetric population, such as
Brazil.14,26
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Conclusion
The placenta has a key role in the understanding of maternalfetal complications. The implementation of the protocol in
different settings would standardize placental sampling and
storage, improving techniques description and results, and
even providing the exchange of samples through different
settings and global locations. The adequate storage of the
samples would allow accurate and biologically relevant
results in future studies to understand possible critical
aspects of viral infections, such as pathogenesis, transmission routes, and functional changes related to infection by
SARS-CoV-2 in the placenta.

4

Contributions
G. M. N. and M. L. C. structured the manuscript and did the
majority of the writing, conception, and design. J. P. S. G., R.
R. J., A. A. T. and I. U. M. were essential for developing the
article and conducting a critical review of the intellectual
content. All authors declare that they have seen and
approved the ﬁnal version of the manuscript.

8

Funding
G. M. N. is supported by Fundação de Amparo à Pesquisa
do Estado de São Paulo – FAPESP (grant number 19/
18720-6) and Coordenação de Aperfeiçoamento Pessoal
de Nível Superior - CAPES (grant number 88887.600190/
2021-00). I. M. is supported in part by a grant from the
National
Institutes
of
Health
(grant
number
R01HD091218). M. L. C. has support from the Conselho
Nacional de Desenvolvimento Cientíﬁco e Tecnológico
(CNPq) (grant number 409605/2016-6) and FAEPEX (grant
number 2300/20). I. M. and M. L. C. have a McDonnell
International Scholars Academy seed grant for research on
infectious diseases and the impact of COVID-19. The
funders had no role in the present study’s design, data
collection and analysis, decision to publish, or preparation
of the manuscript. Figures were created with BioRender.
com. We also acknowledge the medical team at the
REBRACO institutions, especially all the medical residents
involved, for the great help in sample collection during the
childbirth of COVID-19 positive patients, proving that the
implementation of a research protocol is possible, even
facing a pandemic.

5

6

7

9

10

11

12

13

14

15

16

17

18

Conﬂict of Interests
The authors have no conﬂict of interests to declare.
19

References
1 Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The

proximal origin of SARS-CoV-2. Nat Med. 2020;26(04):450–452.
Doi: 10.1038/s41591-020-0820-9
2 Neuman BW, Kiss G, Kunding AH, et al. A structural analysis of M
protein in coronavirus assembly and morphology. J Struct Biol.
2011;174(01):11–22. Doi: 10.1016/j.jsb.2010.11.021
3 Gorbalenya AE, Baker SC, Baric RS, et al; Coronaviridae Study
Group of the International Committee on Taxonomy of Viruses.
The species Severe acute respiratory syndrome-related coronavi-

Rev Bras Ginecol Obstet

Vol. 43

No. 5/2021

20

21

22

rus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(04):536–544. Doi: 10.1038/s41564-020-0695-z
Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what
we know. Infection. 2020;48(02):155–163. Doi: 10.1007/s15010020-01401-y
Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ.
Coronavirus Disease 2019 (COVID-19) and pregnancy: what
obstetricians need to know. Am J Obstet Gynecol. 2020;222
(05):415–426. Doi: 10.1016/j.ajog.2020.02.017
Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal
outcomes of women with severe acute respiratory syndrome. Am
J Obstet Gynecol. 2004;191(01):292–297. Doi: 10.1016/j.ajog.
2003.11.019
Jeong SY, Sung SI, Sung JH, et al. MERS-CoV infection in a pregnant
woman in Korea. J Korean Med Sci. 2017;32(10):1717–1720. Doi:
10.3346/jkms.2017.32.10.1717
Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J
Med. 2014;370(23):2211–2218. Doi: 10.1056/NEJMra1213566
Favre G, Pomar L, Musso D, Baud D. 2019-nCoV epidemic: what
about pregnancies? Lancet. 2020;395(10224):e40. Doi: 10.1016/
S0140-6736(20)30311-1
Breslin N, Baptiste C, Gyamﬁ-Bannerman C, et al. Coronavirus
disease 2019 infection among asymptomatic and symptomatic
pregnant women: two weeks of conﬁrmed presentations to an
afﬁliated pair of New York City hospitals. Am J Obstet Gynecol
MFM. 2020;2(02):100118. Doi: 10.1016/j.ajogmf.2020.100118
Breslin N, Baptiste C, Miller R, et al. Coronavirus disease 2019 in
pregnancy: early lessons. Am J Obstet Gynecol MFM. 2020;2(02):
100111. Doi: 10.1016/j.ajogmf.2020.100111
Knight M, Bunch K, Vousden N, et al; UK Obstetric Surveillance
System SARS-CoV-2 Infection in Pregnancy Collaborative Group.
Characteristics and outcomes of pregnant women admitted to
hospital with conﬁrmed SARS-CoV-2 infection in UK: national
population based cohort study. BMJ. 2020;369:m2107. Doi:
10.1136/bmj.m2107
Ellington S, Strid P, Tong VT, et al. Characteristics of women of
reproductive age with laboratory-conﬁrmed SARS-CoV-2 infection by pregnancy status - United States, January 22–June 7, 2020.
MMWR Morb Mortal Wkly Rep. 2020;69(25):769–775. Doi:
10.15585/mmwr.mm6925a1
Takemoto MLS, Menezes MO, Andreucci CB, et al. The tragedy of
COVID-19 in Brazil: 124 maternal deaths and counting. Int J
Gynaecol Obstet. 2020;151(01):154–156. Doi: 10.1002/ijgo.13300
Maltepe E, Fisher SJ. Placenta: the forgotten organ. Annu Rev Cell
Dev Biol. 2015;31(01):523–552. Doi: 10.1146/annurev-cellbio100814-125620
Proenca-Modena JL, Milanez GP, Costa ML, Judice CC, Maranhão
Costa FT. Zika virus: lessons learned in Brazil. Microbes Infect.
2018;20(11-12):661–669. Doi: 10.1016/j.micinf.2018.02.008
Pereira L. Congenital viral infection: traversing the uterine-placental interface. Annu Rev Virol. 2018;5(01):273–299. Doi:
10.1146/annurev-virology-092917-043236
Costa ML, de Moraes Nobrega G, Antolini-Tavares A. Key infections in the placenta. Obstet Gynecol Clin North Am. 2020;47(01):
133–146. Doi: 10.1016/j.ogc.2019.10.003
Verma S, Carter EB, Mysorekar IU. SARS-CoV2 and pregnancy: An
invisible enemy? Am J Reprod Immunol. 2020;84(05):e13308.
Doi: 10.1111/aji.13308
Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA.
Placental Pathology in COVID-19. Am J Clin Pathol. 2020;154(01):
23–32. Doi: 10.1093/ajcp/aqaa089
He M, Skaria P, Kreutz K, et al. Histopathology of third trimester
placenta from SARS-CoV-2-Positive women. Fetal Pediatr Pathol.
2020:1–10. Doi: 10.1080/15513815.2020.1828517[ahead of
print]
Algarroba GN, Rekawek P, Vahanian SA, et al. Visualization of
severe acute respiratory syndrome coronavirus 2 invading the

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. All rights reserved.

Placental Sampling for Understanding Viral Infections

23

24

25

26

27
28

29

30

31

32

human placenta using electron microscopy. Am J Obstet Gynecol.
2020;223(02):275–278. Doi: 10.1016/j.ajog.2020.05.023
Hecht JL, Quade B, Deshpande V, et al. SARS-CoV-2 can infect the
placenta and is not associated with speciﬁc placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod
Pathol. 2020;33(11):2092–2103. Doi: 10.1038/s41379-020-0639-4
Hosier H, Farhadian SF, Morotti RA, et al. SARS-CoV-2 infection of
the placenta. J Clin Invest. 2020;130(09):4947–4953. Doi:
10.1172/JCI139569
Venceslau EM, Guida JPS, Nobrega GM, et al; Zika-Unicamp
Network. Adequate placental sampling for the diagnosis and
characterization of placental infection by Zika Virus. Front Microbiol. 2020;11:112. Doi: 10.3389/fmicb.2020.00112
Costa ML, Pacagnella RC, Guida JP, et al; Brazilian Network for
Studies on Reproductive and Perinatal Research. Call to action for a
South American network to ﬁght COVID-19 in pregnancy. Int J
Gynaecol Obstet. 2020;150(02):260–261. Doi: 10.1002/ijgo.13225
World Health Organization. Laboratory biosafety manual. 3rd ed.
Geneva: WHO; 2004
World Health Organization. Laboratory biosafety guidance related
to coronavirus disease 2019 (COVID-19): interim recommendations [Internet]. GenevaWHO2020 [cited 2020 May 12]. Available
from: https://apps.who.int/iris/rest/bitstreams/1277819/retrieve
Khong TY, Mooney EE, Ariel I, et al. Sampling and Deﬁnitions of
Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(07):698–713.
Doi: 10.5858/arpa.2015-0225-CC
Ravishankar S, Redline RW. What obstetricians need to know
about placental pathology. Obstet Gynecol Clin North Am. 2020;
47(01):29–48. Doi: 10.1016/j.ogc.2019.10.007
Burton GJ, Sebire NJ, Myatt L, et al. Optimising sample collection
for placental research. Placenta. 2014;35(01):9–22. Doi: 10.1016/
j.placenta.2013.11.005
Zeng L, Xia S, Yuan W, et al. Neonatal early-onset infection with
SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in
Wuhan, China. JAMA Pediatr. 2020;174(07):722–725. Doi:
10.1001/jamapediatrics.2020.0878

Rev Bras Ginecol Obstet

Vol. 43

Nobrega et al.

33 Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of

34

35

36

37

38

39

40

41

42

2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci.
2020;12(01):8. Doi: 10.1038/s41368-020-0074-x
Chen Y, Peng H, Wang L, et al. Infants born to mothers with a New
Coronavirus (COVID-19). Front Pediatr. 2020;8:104. Doi: 10.3389/
fped.2020.00104
Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute
respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–14621
Tai W, He L, Zhang X, et al. Characterization of the receptorbinding domain (RBD) of 2019 novel coronavirus: implication for
development of RBD protein as a viral attachment inhibitor and
vaccine. Cell Mol Immunol. 2020;17(06):613–620. Doi: 10.1038/
s41423-020-0400-4
Levy A, Yagil Y, Bursztyn M, Barkalifa R, Scharf S, Yagil C. ACE2
expression and activity are enhanced during pregnancy. Am J
Physiol Regul Integr Comp Physiol. 2008;295(06):R1953–R1961.
Doi: 10.1152/ajpregu.90592.2008
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell
entry depends on ACE2 and TMPRSS2 and is blocked by a clinically
proven protease inhibitor. Cell. 2020;181(02):271–280.e8. Doi:
10.1016/j.cell.2020.02.052
Lukassen S, Chua RL, Trefzer T, et al. SARS-CoV-2 receptor ACE2
and TMPRSS2 are primarily expressed in bronchial transient
secretory cells. EMBO J. 2020;39(10):e105114. Doi: 10.15252/
embj.20105114
Schwartz DA. An analysis of 38 pregnant women with COVID-19,
their newborn infants, and maternal-fetal transmission of SARSCoV-2: maternal coronavirus infections and pregnancy outcomes.
Arch Pathol Lab Med. 2020. Doi: 10.5858/arpa.2020-0901-SA
[ahead of print]
Li Y, Zhao R, Zheng S, et al. Lack of Vertical Transmission of Severe
Acute Respiratory Syndrome Coronavirus 2, China. Emerg Infect
Dis. 2020;26(06):1335–1336. Doi: 10.3201/eid2606.200287
Liu ZY, Shi WF, Qin CF. The evolution of Zika virus from Asia to the
Americas. Nat Rev Microbiol. 2019;17(03):131–139. Doi: 10.1038/
s41579-018-0134-9

No. 5/2021

© 2021. Federação Brasileira de Ginecologia e Obstetrícia. All rights reserved.

383

